Marshall Wace’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,803
Closed -$934K 3399
2022
Q3
$934K Sell
3,803
-1,632
-30% -$401K ﹤0.01% 1824
2022
Q2
$1.35M Buy
+5,435
New +$1.35M ﹤0.01% 1750
2022
Q1
Sell
-143,416
Closed -$51.5M 3955
2021
Q4
$51.5M Buy
143,416
+113,062
+372% +$40.6M 0.1% 192
2021
Q3
$9.88M Buy
+30,354
New +$9.88M 0.04% 499
2021
Q2
Sell
-17,783
Closed -$5.67M 2939
2021
Q1
$5.67M Buy
17,783
+14,394
+425% +$4.59M 0.03% 696
2020
Q4
$1.1M Buy
3,389
+463
+16% +$150K 0.01% 1055
2020
Q3
$811K Buy
+2,926
New +$811K 0.01% 1064
2020
Q1
Sell
-88
Closed -$15K 2141
2019
Q4
$15K Sell
88
-14
-14% -$2.39K ﹤0.01% 1548
2019
Q3
$18K Sell
102
-38,062
-100% -$6.72M ﹤0.01% 1558
2019
Q2
$9.94M Buy
38,164
+33,615
+739% +$8.76M 0.08% 269
2019
Q1
$1.3M Buy
4,549
+1,219
+37% +$348K 0.01% 852
2018
Q4
$1.08M Sell
3,330
-40,010
-92% -$13M 0.01% 893
2018
Q3
$19.5M Buy
43,340
+21,771
+101% +$9.79M 0.17% 170
2018
Q2
$8.82M Buy
21,569
+15,449
+252% +$6.32M 0.13% 197
2018
Q1
$1.78M Sell
6,120
-2,710
-31% -$789K 0.07% 205
2017
Q4
$1.66M Buy
8,830
+126
+1% +$23.6K 0.07% 207
2017
Q3
$1.47M Buy
+8,704
New +$1.47M 0.07% 189
2017
Q1
Sell
-55,113
Closed -$6.21M 829
2016
Q4
$6.21M Buy
55,113
+19,858
+56% +$2.24M 0.04% 422
2016
Q3
$4.53M Sell
35,255
-21,620
-38% -$2.78M 0.03% 429
2016
Q2
$6.22M Buy
56,875
+43,556
+327% +$4.76M 0.05% 335
2016
Q1
$1.26M Buy
13,319
+1,285
+11% +$122K 0.01% 661
2015
Q4
$1.09M Sell
12,034
-69,416
-85% -$6.26M 0.01% 691
2015
Q3
$7.56M Buy
81,450
+47,737
+142% +$4.43M 0.09% 220
2015
Q2
$2.22M Buy
+33,713
New +$2.22M 0.03% 459